141 related articles for article (PubMed ID: 28255316)
1. Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells.
Atari-Hajipirloo S; Nikanfar S; Heydari A; Kheradmand F
Res Pharm Sci; 2017 Feb; 12(1):67-73. PubMed ID: 28255316
[TBL] [Abstract][Full Text] [Related]
2. The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes expression.
Atari-Hajipirloo S; Nikanfar S; Heydari A; Noori F; Kheradmand F
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):68-74. PubMed ID: 26950454
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line.
Nikanfar S; Atari-Hajipirloo S; Kheradmand F; Rashedi J; Heydari A
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):8-13. PubMed ID: 29974839
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
[TBL] [Abstract][Full Text] [Related]
8. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
9. The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma.
van Roosmalen IAM; Reis CR; Setroikromo R; Yuvaraj S; Joseph JV; Tepper PG; Kruyt FAE; Quax WJ
Springerplus; 2014; 3(1):495. PubMed ID: 26331107
[TBL] [Abstract][Full Text] [Related]
10. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
11. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402
[TBL] [Abstract][Full Text] [Related]
12. 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.
Kulp SK; Yang YT; Hung CC; Chen KF; Lai JP; Tseng PH; Fowble JW; Ward PJ; Chen CS
Cancer Res; 2004 Feb; 64(4):1444-51. PubMed ID: 14973075
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl celecoxib sensitizes gastric cancer cells to ABT-737 via AIF nuclear translocation.
Zhang B; Yan Y; Li Y; Zhang D; Zeng J; Wang L; Wang M; Lin N
J Cell Mol Med; 2016 Nov; 20(11):2148-2159. PubMed ID: 27374973
[TBL] [Abstract][Full Text] [Related]
14. Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy.
Schönthal AH
Neurosurg Focus; 2006 Apr; 20(4):E21. PubMed ID: 16709027
[TBL] [Abstract][Full Text] [Related]
15. Dimethoxy Curcumin Induces Apoptosis by Suppressing Survivin and Inhibits Invasion by Enhancing E-Cadherin in Colon Cancer Cells.
Chen D; Dai F; Chen Z; Wang S; Cheng X; Sheng Q; Lin J; Chen W
Med Sci Monit; 2016 Sep; 22():3215-22. PubMed ID: 27614381
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
Backhus LM; Petasis NA; Uddin J; Schönthal AH; Bart RD; Lin Y; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1406-12. PubMed ID: 16256796
[TBL] [Abstract][Full Text] [Related]
17. Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells.
Abdel-Aziz AK; Azab SS; Youssef SS; El-Sayed AM; El-Demerdash E; Shouman S
Basic Clin Pharmacol Toxicol; 2015 Jan; 116(1):37-46. PubMed ID: 24930392
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
19. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant-p53 Colorectal Cancer Cells to γ-Irradiation.
Hosseini F; Sam MR; Jabbari N; Mozdarani H
Cancer Biother Radiopharm; 2018 Nov; 33(9):387-395. PubMed ID: 30395490
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
